HemaSphere
(Jun 2022)
P763: VENETOCLAX WITH AZACITIDINE IN RELAPSE/REFRACTORY HIGHER RISK MYELODYSPLASTIC SYNDROME: UPDATED PHASE 1 RESULTS
- S. P. Desikan,
- G. Montalban-Bravo,
- M. Ohanian,
- N. Daver,
- T. Kadia,
- S. Venugopal,
- K. Chien,
- H. Kantarjian,
- G. Garcia-Manero
Affiliations
- S. P. Desikan
- 1 Leukemia, MD Anderson, houston, United States of America
- G. Montalban-Bravo
- 1 Leukemia, MD Anderson, houston, United States of America
- M. Ohanian
- 1 Leukemia, MD Anderson, houston, United States of America
- N. Daver
- 1 Leukemia, MD Anderson, houston, United States of America
- T. Kadia
- 1 Leukemia, MD Anderson, houston, United States of America
- S. Venugopal
- 1 Leukemia, MD Anderson, houston, United States of America
- K. Chien
- 1 Leukemia, MD Anderson, houston, United States of America
- H. Kantarjian
- 1 Leukemia, MD Anderson, houston, United States of America
- G. Garcia-Manero
- 1 Leukemia, MD Anderson, houston, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000845936.76506.6b
- Journal volume & issue
-
Vol. 6
pp.
658
– 659
WeChat QR code